Articles
How a CDMO Achieves Finished Product Lyophilization with Limited and Expensive API
Partnering with a CDMO like Pii can progress your drug’s parenteral delivery from early-stage development concept to clinic. Pii can fill cartridges for use with a customer’s pen device, for a variety of products, including biologics. Supporting a range of therapies that require frequent injections and variable dosing, the 3mL cartridge in combination with a pen device can improve patient compliance.
Read MoreSelf-Injection of Biologics Made Easy
Partnering with a CDMO like Pii can progress your drug’s parenteral delivery from early-stage development concept to clinic. Pii can fill cartridges for use with a customer’s pen device, for a variety of products, including biologics. Supporting a range of therapies that require frequent injections and variable dosing, the 3mL cartridge in combination with a pen device can improve patient compliance.
Read MoreSnapshot of the Parenteral Drug Delivery Market
Parenterals are sterile preparations containing one or more active ingredients for administration by injection – the most commonly used and long-lasting method for administration of the drug. Parenteral administration allows direct administration of drug substances and to ensure bioavailability. Growth in the development of parenteral drugs is driving demand for advanced drug delivery devices such as prefilled syringes, auto-injectors, and pen-injectors, growing segments in the fill-finish manufacturing market.
Read MoreArtful Taste Masking Improves Patient Compliance
Oxygen is the second leading cause for quality degradation of pharmaceuticals, water being the first. While we typically think of packaging as the primary resource used to protect drugs from the negative effects of oxygen, there are things to consider during development and manufacturing to make sure excess oxygen isn’t simply packaged or bottled with the drug product.
Read MoreDosage Form Focus Oral Solutions & Suspensions: The Art of Pharmacy
Oxygen is the second leading cause for quality degradation of pharmaceuticals, water being the first. While we typically think of packaging as the primary resource used to protect drugs from the negative effects of oxygen, there are things to consider during development and manufacturing to make sure excess oxygen isn’t simply packaged or bottled with the drug product.
Read MoreWhat You Didn’t Know About Dr. Tom
Oxygen is the second leading cause for quality degradation of pharmaceuticals, water being the first. While we typically think of packaging as the primary resource used to protect drugs from the negative effects of oxygen, there are things to consider during development and manufacturing to make sure excess oxygen isn’t simply packaged or bottled with the drug product.
Read MoreHow to Clear 5 Early-Stage Development Hurdles
Oxygen is the second leading cause for quality degradation of pharmaceuticals, water being the first. While we typically think of packaging as the primary resource used to protect drugs from the negative effects of oxygen, there are things to consider during development and manufacturing to make sure excess oxygen isn’t simply packaged or bottled with the drug product.
Read MoreThe Importance of Early-Stage Development
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos The Importance of Early-Stage Development By: Devan Patel, Vice President of Client Services To avoid the risks, costs, and possible pitfalls that typically terminate projects during later stages of drug development, it’s important for…
Read MoreSmall CDMOs Can Save The Supply Chain
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos Small CDMOs Can Save The Supply Chain According to the Harvard Business Review, the US Food and Drug Administration (FDA) currently lists shortages of 115 basic drugs. And the American Medical Association (AMA) considers…
Read MoreThe Role of a CDMO in the Fill-Finish of Large-Molecule Injectables
BACK TO RESOURCE CENTER Other Content Guide to Aseptic ManufacturingGuide to Oral Dose ManufacturingArticlesBrochuresBy The NumbersCase StudiesMeet the ScientistNewslettersPress ReleasesTrade ShowsVideos The Role of a CDMO in the Fill-Finish of Large-Molecule Injectables By Devan Patel, Vice President of Client Services Since the passing of the Biologics Control Act in 1902, the large-molecule sector is emerging…
Read More